January 2009
CMAJ: Canadian Medical Association Journal;1/6/2009, Vol. 180 Issue 1, p79
Academic Journal
Correction notice
The article presents corrections to articles including "Cancer in Canada in 2008" that was published on November 18, 2008 issue, "Respiratory flouroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials" that was published on December 2, 2008 issue, and "Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes" that was published in December 2, 2008 issue.


Related Articles

  • Uterine artery embolization with methotrexate infusion as treatment for cesarean scar pregnancy. Case report. Júnior, Julio Elito; Júnior, Edward Araujo; Santana, Eduardo Félix Martins; Szejnfeld, Denis; Helfer, Talita Micheletti; Nardozza, Luciano Marcondes Machado; Moron, Antonio Fernandes // Medical Ultrasonography;Sep2013, Vol. 15 Issue 3, p240 

    Cesarean scar pregnancy is a rare form of ectopic pregnancy. It is associated with many complications, including a high risk of massive bleeding and hysterectomy under unfavorable conditions. Conservative treatment with systemic methotrexate (MTX) has been used preferentially with the aim of...

  • Effects of Folate Supplementation on Two Provisional Molecular Markers of Colon Cancer: A Prospective, Randomized Trial. Young-In Kim; Hyun Wook Baik; Fawaz, Karim; Knox, Tamsin; Young Mee; Norton, Richard; Libby, Eric; Mason, Joel B // American Journal of Gastroenterology;Jan2001, Vol. 96 Issue 1, p184 

    OBJECTIVES: Dietary folate intake is Inversely associated with the risk of colorectal cancer. This study investigated the effect of folate supplementation on genomic DNA methylation and DNA strand breaks in exons 5-8 of the p53 gene of the colonic mucosa. two provisional biomarkers of colon...

  • Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis. Ali, Nemat; Rashid, Summya; Nafees, Sana; Hasan, Syed Kazim; Sultana, Sarwat // Molecular & Cellular Biochemistry;Jan2014, Vol. 385 Issue 1/2, p215 

    Methotrexate (MTX), a folic acid antagonist, an effective chemotherapeutic agent is used in the treatment of a wide range of tumors and autoimmune diseases. Moreover, hepatotoxicity limits its clinical use. Several studies have already confirmed that the oxidative stress plays a major role in...

  • Can studies of harm be harmful? Ray, Joel G. // CMAJ: Canadian Medical Association Journal;12/2/2008, Vol. 179 Issue 12, p1243 

    The author reflects on the study by Wen and colleagues on the use of folic acid antagonists which is associated to higher risk of placenta-mediated outcomes of pregnancy. He argues that the findings should not alter medical practice because of limited analysis of drug exposure and unreported...

  • Treatment of Unruptured Ectopic Pregnancy.  // Fertility Weekly;7/25/2005, p1 

    Focuses on the study from Brazil which stated that in the treatment of unruptured ectopic pregnancy, tubal patency rates are similar when treated with methotrexate and expectant management. Changes in the developments in diagnostics for the treatment of ectopic pregnancy from that of saving the...

  • Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias. You, B.; Pollet-Villard, M.; Fronton, L.; Labrousse, C.; Schott, A.-M.; Hajri, T.; Girard, P.; Freyer, G.; Tod, M.; Tranchand, B.; Colomban, O.; Ribba, B.; Raudrant, D.; Massardier, J.; Chabaud, S.; Golfier, F. // Annals of Oncology;Aug2010, Vol. 21 Issue 8, p1643 

    Background: Early identification of patients at high risk for chemoresistance among those treated with methotrexate (MTX) for low-risk gestational trophoblastic neoplasia (GTN) is needed. We modeled human chorionic gonadotropin (hCG) decline during MTX therapy using a kinetic population approach...

  • Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes. Shi Wu Wen; Jia Zhou; Qiuying Yang; Fraser, William; Olatunbosun, Olufemi; Walker, Mark // CMAJ: Canadian Medical Association Journal;12/2/2008, Vol. 179 Issue 12, p1263 

    Background: In previous studies, maternal exposure to folic acid antagonists was associated with increased risks of neural tube defects, cardiovascular defects, oral clefts and urinary tract defects. The objective of the current study was to assess the possible effects of using folic acid...

  • Plasma Folate Level and High-Dose Folate Supplementation Predict Sulfadoxine-Pyrimethamine Treatment Failure in Pregnant Women in Western Kenya Who Have Uncomplicated Malaria. van Eijk, Anna M.; Ouma, Peter O.; Williamson, John; Ter Kuile, Feiko O.; Parise, Monica; Otieno, Kephas; Hamel, Mary J.; Ayisi, John G.; Kariuki, Simon; Kager, Piet A.; Slutsker, Laurence // Journal of Infectious Diseases;11/15/2008, Vol. 198 Issue 10, p1550 

    Sulfadoxine-pyrimethamine (SP) inhibits folate metabolism by the malaria parasite. We investigated the association between folate levels and SP failure in pregnant women. Data from a trial to assess the effect that folate supplementation has on SP failure in 467 pregnant women were analyzed....

  • Safety and Efficacy of Pemetrexed in Maintenance Therapy of Non-Small Cell Lung Cancer. Velez, Michel; Arango, Belisario A.; Perez, Cesar A.; Santos, Edgardo S. // Clinical Medicine Insights: Oncology;2012, Issue 6, p117 

    Lung cancer incidence continues to rise and is the number one cause of cancer death in both men and women worldwide with projected 221,130 new cases and 156,940 deaths in the United States in 2011. Non-small cell lung cancer (NSCLC) represents more than 85% of the cases with most patients having...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics